Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zimmer Biomet Supply Woes Could Leave An Opening In Joint Markets

Executive Summary

Zimmer Biomet said it was not able to maintain supply to meet strong demand for its hip, knee and other joint products that grew out of cross-selling opportunities. As a result, the firm fell short of financial expectations in Q3. The company said it is working to improve its supply-chain procedures, but there could be a short-term chance for competitors to make some gains, analysts suggest.


Related Content

Zimmer Biomet Buys LDR To Boost Spine Revenue Growth


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts